IPO ROUND-UP: Invuity and Endochoice lower the bar, but IPO hopefuls keep coming
This article was originally published in Clinica
Executive Summary
Lowering one’s expectations is becoming the unfortunate norm when it comes to medtech IPOs. Since last month, Clinica has added two more downsized public market debuts, which means of the 13 completed IPOs recorded for the year to date, nine raised less money than they had initially hoped (see Table 1). The two new additions to Clinica’s IPO tracker are Invuity and EndoChoice, both in the field of minimally invasive surgery.